Pres, CEO
Xingjuan (Jane) Chao, Ph.D., also known as Jane Chao, is the President, CEO, Co-Founder, and Director of Ceribell, Inc. (CBLL), a medical technology company based in Sunnyvale, California, specializing in AI-powered brain monitoring for diagnosing and managing serious neurological conditions like seizures and delirium.[[1]](https://fintool.com/app/research/companies/CBLL/people/jane-chao)[[3]](https://www.fogartyinnovation.org/an-afternoon-with-ceribells-jane-chao/)[[5]](https://www.quiverquant.com/news/CeriBell,+Inc.+CEO+Jane+Chao+to+Present+at+44th+Annual+J.P.+Morgan+Healthcare+Conference) She has served as a director since August 2015, CEO since October 2015, and President since July 2016.[[1]](https://fintool.com/app/research/companies/CBLL/people/jane-chao) Chao holds a B.S. in Chemistry from Peking University and a Ph.D. in Biophysics from Cornell University.[[1]](https://fintool.com/app/research/companies/CBLL/people/jane-chao)[[4]](https://www.youtube.com/watch?v=X6DqSgNGXZc)
Prior to founding Ceribell with two Stanford professors, Chao built a distinguished career in healthcare and consulting, including roles as a management consultant at McKinsey & Company, Senior Strategy Manager at Novartis, and Principal Manager of Portfolio Management Strategy at Genentech.[[3]](https://www.fogartyinnovation.org/an-afternoon-with-ceribells-jane-chao/)[[4]](https://www.youtube.com/watch?v=X6DqSgNGXZc) Under her leadership, Ceribell developed its FDA-cleared Ceribell System, addressing a $2 billion market for 3 million U.S. patients annually with critical neurological issues.[[3]](https://www.fogartyinnovation.org/an-afternoon-with-ceribells-jane-chao/)[[5]](https://www.quiverquant.com/news/CeriBell,+Inc.+CEO+Jane+Chao+to+Present+at+44th+Annual+J.P.+Morgan+Healthcare+Conference) Recently, as of January 5, 2026, she sold 54,000 shares for $1.68 million under a Rule 10b5-1 plan while exercising options, maintaining significant ownership of approximately 741,248 shares directly and 369,088 indirectly.[[2]](https://www.investing.com/news/insider-trading-news/ceribell-ceo-chao-xingjuan-sells-168-million-in-shares-93CH-4436040) She presented at the 44th Annual J.P. Morgan Healthcare Conference in January 2026.[[5]](https://www.quiverquant.com/news/CeriBell,+Inc.+CEO+Jane+Chao+to+Present+at+44th+Annual+J.P.+Morgan+Healthcare+Conference)
View full insider profile →
